2023
Obesity and Peripheral Artery Disease: Current Evidence and Controversies
Lempesis I, Varrias D, Sagris M, Attaran R, Altin E, Bakoyiannis C, Palaiodimos L, Dalamaga M, Kokkinidis D. Obesity and Peripheral Artery Disease: Current Evidence and Controversies. Current Obesity Reports 2023, 12: 264-279. PMID: 37243875, PMCID: PMC10220347, DOI: 10.1007/s13679-023-00510-7.Peer-Reviewed Original ResearchConceptsPeripheral artery diseaseArtery diseaseCurrent evidenceLower extremity peripheral artery diseaseHigher Body Mass IndexSignificant public health problemPurpose of ReviewObesityPresence of obesityPotential pathophysiologic mechanismsRisk of morbidityBody mass indexBody fat distributionProgression of atherosclerosisMajor risk factorPublic health problemPotential protective roleMendelian randomization studyObesity paradoxAggressive treatmentCardiovascular manifestationsMass indexNormal weightPad developmentPathophysiologic mechanismsRisk factors
2016
P-220 To Assess the Rate of Adequate Immune Response to Primary Hepatitis B Vaccination Series in Patients with IBD
Phatak U, Rojas-Velasquez D, Pashankar D. P-220 To Assess the Rate of Adequate Immune Response to Primary Hepatitis B Vaccination Series in Patients with IBD. Inflammatory Bowel Diseases 2016, 22: s76-s76. DOI: 10.1097/01.mib.0000480330.52952.bf.Peer-Reviewed Original ResearchInflammatory bowel diseaseAdequate immune responseType of IBDHep B vaccinationAnti-TNF therapyImmune responseHBsAb levelsVaccination seriesHep BB vaccinationMIU/General populationHepatitis B vaccination seriesYale-New Haven Children's HospitalHepatitis B surface antigenHepatitis B surface antibodyPrimary vaccination seriesPercent of patientsPresence of obesityRetrospective chart reviewHepatitis B vaccineInadequate immune responseUse of immunomodulatorsB surface antigenB surface antibody
2012
Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI
Flannery CA, Rackow B, Cong X, Duran E, Selen DJ, Burgert TS. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI. Pediatric Diabetes 2012, 14: 42-49. PMID: 22925367, PMCID: PMC4864958, DOI: 10.1111/j.1399-5448.2012.00902.x.Peer-Reviewed Original ResearchConceptsOral glucose tolerance testingPolycystic ovary syndromeAbnormal glucose metabolismGlucose metabolismOB cohortOvary syndromeGlucose toleranceAndrogen Excess Society criteriaHomeostatic model assessmentPresence of obesityGlucose tolerance testingC-reactive proteinType 2 diabetesNon-obese adolescentsHigh-density lipoproteinInsulin levelsInsulin resistanceSubgroup analysisChronic conditionsMetabolic manifestationsReproductive yearsSociety criteriaLipid profileTolerance testingTestosterone levels
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply